![Dana Levasseur](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Dana Levasseur worked as a Director at Bioverativ, Inc. from 2017 to 2018 and as a Vice President-Haematology at Beam Therapeutics, Inc. from 2018 to 2020.
He holds a doctorate degree from The University of Alabama at Birmingham.
Eerdere bekende functies van Dana Levasseur
| Bedrijven | Functie | Einde |
|---|---|---|
| BEAM THERAPEUTICS INC. | Corporate Officer/Principal | 01-04-2020 |
| BIOVERATIV INC | Directeur/Bestuurslid | 01-06-2018 |
Opleiding van Dana Levasseur
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
The University of Alabama at Birmingham
 The University of Alabama at Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
